Senores Pharma. (SENORES)
FAST GROWERFairStock Score: 42/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹900.65 |
| Market Cap | ₹3,522.64 Cr |
| P/E Ratio | 34.67 |
| ROCE | 11.4% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 84.28% |
| Debt/Equity | 0.29 |
| Sales Growth | 69.44% |
| Promoter Holding | 45.8% |
| 52-Week Range | ₹513 — ₹1,295 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹164.41 |
Senores Pharma. trades with a P/E ratio of 34.67, ROCE of 11.4%, profit growth of 84.28%, debt-to-equity of 0.29. The FairStock Score of 42/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer